Eastgate Biotech (ETBI) Price & Analysis

12 Followers

ETBI Stock Chart & Stats

$0.01

$0.00(0.00%)

At close: May 28 4:00 PM EDT

$0.01

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.01

Previous CloseN/A

Volume1.50K

Average Volume (3M)N/A

Market Cap

$6.77M

Enterprise Value$10.67M

Total Cash (Recent Filing)$4.91K

Total Debt (Recent Filing)$3.08M

Price to Earnings (P/E)―

Beta-1467.25

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding2,057,546,000

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio-0.07

Price to Book (P/B)-1.50

Price to Sales (P/S)145.15

P/FCF Ratio240.55

Enterprise Value/Market Cap1.58

Enterprise Value/Revenue241.82

Enterprise Value/Gross Profit-116.97

Enterprise Value/Ebitda-5.91

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ETBI FAQ

What was Eastgate Biotech Corp’s price range in the past 12 months?

Eastgate Biotech Corp lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is Eastgate Biotech Corp’s market cap?

Eastgate Biotech Corp’s market cap is $6.77M.

When is Eastgate Biotech Corp’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Eastgate Biotech Corp’s earnings last quarter?

Currently, no data Available

Is Eastgate Biotech Corp overvalued?

According to Wall Street analysts Eastgate Biotech Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Eastgate Biotech Corp pay dividends?

Eastgate Biotech Corp does not currently pay dividends.

What is Eastgate Biotech Corp’s EPS estimate?

Eastgate Biotech Corp’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Eastgate Biotech Corp have?

Eastgate Biotech Corp has 2,057,546,000 shares outstanding.

What happened to Eastgate Biotech Corp’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Eastgate Biotech Corp?

Currently, no hedge funds are holding shares in ETBI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Eastgate Biotech Corp

EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.